These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11229278)

  • 1. Pictorial CME. Familial insulin resistance syndrome--Kahn type A with face sparing lipo-dystrophy.
    Vaidya RA; Shringi MS; Mehtalia SD; Talwalkar SC; Vaidya AB
    J Assoc Physicians India; 1998 Aug; 46(8):705. PubMed ID: 11229278
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relationship between insulin binding and insulin effect in a special form of insulin resistance].
    Dörfler H; Wieczorek A; Barth C; Wolfram G; Zöllner N
    Verh Dtsch Ges Inn Med; 1978; (84):1204-6. PubMed ID: 741928
    [No Abstract]   [Full Text] [Related]  

  • 3. [Partial progressive lipoatrophy. A new case-report (author's transl)].
    Moinade S; Thieblot P; Laurens D; Lambert M; Cailleba A
    Sem Hop; 1982 Jan; 58(1):45-9. PubMed ID: 6275548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Invitation to join the international study group on Berardinelli-Seip syndrome/ lipoatrophic diabetes in the clinical and genetic study of lipoatrophic diabetes].
    Capeau J; Magré J
    Diabetes Metab; 1996 Jul; 22(4):279-81. PubMed ID: 8767176
    [No Abstract]   [Full Text] [Related]  

  • 5. [Body building and diabetes?].
    Truniger B
    Schweiz Med Wochenschr; 1998 Jan; 128(1-2):45. PubMed ID: 9491472
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of lipo-atrophic diabetes].
    Romero E; Romero Bobillo E
    Rev Iber Endocrinol; 1970; 17(101):391-7. PubMed ID: 5501996
    [No Abstract]   [Full Text] [Related]  

  • 7. Ectodermal dysplasia, lipoatrophy, diabetes mellitus, and amastia: a second case of the AREDYLD syndrome.
    Breslau-Siderius EJ; Toonstra J; Baart JA; Koppeschaar HP; Maassen JA; Beemer FA
    Am J Med Genet; 1992 Oct; 44(3):374-7. PubMed ID: 1488989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
    da Silva RC; Miranda WL; Chacra AR; Dib SA
    J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of diet upon carbohydrate metabolism, insulin resistance, and blood pressure in congenital total lipoatrophic diabetes.
    Keenan BS; Kirland RT; Garber AJ; Rubenstein AH; Holcombe JH; Potts VE; Clayton GW
    Metabolism; 1980 Dec; 29(12):1214-24. PubMed ID: 7005617
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lipoatrophic diabetes].
    Kusakabe T; Ebihara K; Nakao K
    Nihon Rinsho; 2006 Sep; Suppl 3():110-3. PubMed ID: 17022511
    [No Abstract]   [Full Text] [Related]  

  • 11. Altered glucose transport conferring post-receptor insulin resistance to a patient with lipoatrophic diabetes.
    Capeau J; Le Luyer B
    Diabete Metab; 1984 Dec; 10(5):336-7. PubMed ID: 6397368
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lipoatrophic diabetes: review of the literature].
    de Pablos Velasco PL; Martínez-Martín FJ; García Puente I
    Rev Clin Esp; 1996 Oct; 196(10):710-3. PubMed ID: 9005476
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.
    Berria R; Gastaldelli A; Lucidi S; Belfort R; De Filippis E; Easton C; Brytzki R; Cusi K; Jovanovic L; DeFronzo R
    Clin Pharmacol Ther; 2006 Aug; 80(2):105-14. PubMed ID: 16890572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipodystrophy in patients with juvenile dermatomyositis--evaluation of clinical and metabolic abnormalities.
    Huemer C; Kitson H; Malleson PN; Sanderson S; Huemer M; Cabral DA; Chanoine JP; Petty RE
    J Rheumatol; 2001 Mar; 28(3):610-5. PubMed ID: 11296968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Partial dominant lipoatrophy: therapeutic contributions].
    Moreno Moreno E; Escolar Castellón JL; Cuenca Guerrero A; Bilbao Guerrero JM
    Rev Clin Esp; 1997 Dec; 197(12):858-9. PubMed ID: 9477684
    [No Abstract]   [Full Text] [Related]  

  • 16. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V; Nagamani M
    J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome.
    Sir-Petermann T; Angel B; Maliqueo M; Carvajal F; Santos JL; Pérez-Bravo F
    Diabetologia; 2002 Jul; 45(7):959-64. PubMed ID: 12136394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha -238G>A genotype alters postprandial plasma levels of free fatty acids in obese individuals with type 2 diabetes mellitus.
    Fontaine-Bisson B; Wolever TM; Chiasson JL; Rabasa-Lhoret R; Maheux P; Josse RG; Leiter LA; Rodger NW; Ryan EA; El-Sohemy A
    Metabolism; 2007 May; 56(5):649-55. PubMed ID: 17445540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipo-atrophic diabetes, "a rare disease of adipocytes?"].
    Clément K; Basdevant A; Guy-Grand B
    Rev Prat; 1994 May; 44(10):1329-32. PubMed ID: 7939193
    [No Abstract]   [Full Text] [Related]  

  • 20. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.